Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» TC-5214
TC-5214
The U.S. Antidepressant Market: Old Fashioned Branding Might Save the Day
Motley Fool
Fri, 07/19/13 - 10:31 am
antidepressants
AstraZeneca
Eli Lilly
Forest Labs
GSK
Pfizer
Targacept
Cymbalta
Lexapro
Effexor
Pristiq
TC-5214
Targacept moving forward with trials for schizophrenia treatment
Winston-Salem Journal, NC
Mon, 04/22/13 - 11:16 am
schizophrenia
Targacept
TC-5214
AstraZeneca officially terminates TC-5214 licensing agreement with Targacept
Seeking Alpha
Tue, 05/1/12 - 09:11 am
AstraZeneca
TC-5214
Targacept
depression
AstraZeneca abandoning anti-ovarian cancer drug, warns antidepressant not testing well
Yahoo/AP
Tue, 12/20/11 - 10:50 am
antidepressants
Targacept
ovarian cancer
AstraZeneca
TC-5214
olaparib
Targacept: What's Left After Latest TC-5214 Disappointment?
Seeking Alpha
Tue, 12/20/11 - 10:25 am
TC-5214
Targacept
AstraZeneca
depression
AstraZeneca says new antidepressant not ready for pharmaceutical sales in U.S.
medreps
Sat, 11/12/11 - 12:57 pm
TC-5214
AstraZeneca
antidepressants
Targacept Depression Drug Fails Late-Stage Study
TheStreet.com
Tue, 11/8/11 - 10:32 am
depression
Targacept
AstraZeneca
TC-5214
Targacept, AstraZeneca begin new trial
Bizjournals.com
Mon, 02/7/11 - 11:21 am
AstraZeneca
Targacept
TC-5214
major depressive disorder